Become A Featured Company

Agreements, Technology Points the Way for Hempsana

Robin Lefferts

August 16th, 2021

News, Top Story

Cannabis 2.0 products, such as edibles, vapes, and oils, are gaining market share across Canada while sales of flower products remain relatively flat. For many licensed producers, the next step in their growth is to provide such products, but they don’t possess the technology, facilities, or expertise to create those offerings on their own. Enter extractors, companies with the ability to not only extract active ingredients like THC and CBD from cannabis and hemp but also to formulate and manufacture unique high quality end products for their licensed customers.

There is a relatively new extractor in the Canadian market, Hempsana Holdings Ltd. (CSE: HMPS), making headway after going public on July 15, 2021. Since then, the company has signed two new agreements in addition to their previous contracts and is eyeing a relatively unexplored niche in the market – rare cannabinoid extraction.

New Agreements

Right out of the pubco gate, Hempsana announced three processing agreements with Canadian licensed producers. The first deal with Lune Rise Farms, an Ontario-based cannabis cultivator, has Hempsana processing about 400kg of cannabis to derive full spectrum THC distillate. Distillates are used in vapes, and as ingredients in edibles and topicals, exactly the growth segments Hempsana is targeting with its services.

The two companies followed up with a more extensive agreement three weeks later, with Hempsana set to extract full spectrum oil from several unique strains developed by Lune Rise. Hempsana will then create finished products, including premium vape SKUs, on a white label basis for Lune Rise to sell into the consumer market. This type of white label manufacturing is central to Hempsana’s business model and a service that is in much demand from the many licensed producers that lack the capabilities to take a product from extraction through formulation to production and packaging.

Download the company’s investor presentation and receive corporate updates

The third deal is a processing agreement with New Leaf Canada, a licensed hemp and cannabis grower, for the extraction of full spectrum CBD crude oil from 2,000kg of hemp. CBD crude is used on its own, dropped under the tongue or added to food and drink. Since it is minimally processed, full spectrum crude oil retains as much of the whole plant’s characteristics as possible, including the terpene and flavonoid profiles of the original plant.

These agreements add to previous deals for the processing of 50,000kg of biomass, and the company’s 8,000 SF EU GMP-compliant is operating ahead of schedule at 80% capacity as a result.

CEO Randy Ko discusses some of Hempsana’s agreements with CFN Media

 Hempsana’s capabilities aren’t limited to extraction arrangements like those discussed above. The company is also developing its own product formulations for the health and wellness sector, with 18 products and 50 SKUs anticipated by the end of the year. Hempsana also offers product formulation and white label end product manufacturing to clients, further broadening its potential market reach.

Click image to view B-TV Interview with Hempsana CEO Randy Ko

Rare Cannabinoids

In the above clip, CEO Randy Ko discusses the company’s plan to branch out beyond CBD and THC into the market for rare cannabinoids. As the research into cannabis science grows almost exponentially, we are learning more and more about the more than 100 cannabinoids found in cannabis and hemp plants.

With current extractors focused heavily on THC and CBD, Hempsana sees an opportunity to be an early mover in the market for lesser-known cannabinoids. To that end, Hempsana has invested in technology that makes extraction of lower concentration cannabinoids both possible and economically viable. The company is also taking advantage of relatively depressed prices for hemp and cannabis raw materials to fuel its research and development of these rare cannabinoids.

“We’ve made some investments into technology that allows the capability of producing rare cannabinoids. We feel like we’ll be one of the first, if not the first, LP (Licensed Producer) in the marketspace to release these types of products,” says Ko.

Where It’s Headed

Following its recent go-public event, Hempsana is wasting no time in building its revenue stream with bulk extraction agreements which have accelerated the company’s projected development timeline. More of these arrangements may be on the way, while the company is planning to introduce its own health and wellness products by the end of 2021. Other catalysts could include progress on the rare cannabinoid front, as well as potential expansion of its current Canadian market into areas such as the European Union and the United States. Stay tuned.

Download the company’s investor presentation and receive corporate updates

Disclaimer

The above article is sponsored content. CannabisFN.com and CFN Media, have been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: https://cannabisfn.com/legal-disclaimer/

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Robin Lefferts

Robin Lefferts has been involved in the legal cannabis industry since 2012, sometimes as an active participant and always as an interested observer.

Network Partners

Follow Us on Social Media

LinkedIn

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading